Your browser doesn't support javascript.
loading
Impaired endothelium-mediated cerebrovascular reactivity promotes anxiety and respiration disorders in mice.
Wenzel, Jan; Hansen, Cathrin E; Bettoni, Carla; Vogt, Miriam A; Lembrich, Beate; Natsagdorj, Rentsenkhand; Huber, Gianna; Brands, Josefine; Schmidt, Kjestine; Assmann, Julian C; Stölting, Ines; Saar, Kathrin; Sedlacik, Jan; Fiehler, Jens; Ludewig, Peter; Wegmann, Michael; Feller, Nina; Richter, Marius; Müller-Fielitz, Helge; Walther, Thomas; König, Gabriele M; Kostenis, Evi; Raasch, Walter; Hübner, Norbert; Gass, Peter; Offermanns, Stefan; de Wit, Cor; Wagner, Carsten A; Schwaninger, Markus.
Affiliation
  • Wenzel J; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany; jan.wenzel@uni-luebeck.de markus.schwaninger@uni-luebeck.de.
  • Hansen CE; DZHK (German Research Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
  • Bettoni C; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Vogt MA; Institute of Physiology, University of Zürich, CH-8057 Zürich, Switzerland.
  • Lembrich B; Central Institute of Mental Health, Medical Faculty of Mannheim/University of Heidelberg, 68159 Mannheim, Germany.
  • Natsagdorj R; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Huber G; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Brands J; DZHK (German Research Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
  • Schmidt K; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Assmann JC; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Stölting I; DZHK (German Research Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
  • Saar K; DZHK (German Research Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
  • Sedlacik J; Institute of Physiology, University of Lübeck, 23562 Lübeck, Germany.
  • Fiehler J; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Ludewig P; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Wegmann M; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.
  • Feller N; DZHK (German Research Centre for Cardiovascular Research), partner site Berlin, 13125 Berlin, Germany.
  • Richter M; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Müller-Fielitz H; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • Walther T; Department of Neurology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
  • König GM; Priority Area Asthma and Allergy, Research Center Borstel, 23845 Borstel, Germany.
  • Kostenis E; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Raasch W; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Hübner N; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Gass P; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Offermanns S; Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany.
  • de Wit C; Institute for Pharmaceutical Biology, University of Bonn, 53115 Bonn, Germany.
  • Wagner CA; Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23562 Lübeck, Germany.
  • Schwaninger M; DZHK (German Research Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.
Proc Natl Acad Sci U S A ; 117(3): 1753-1761, 2020 01 21.
Article in En | MEDLINE | ID: mdl-31896584
ABSTRACT
Carbon dioxide (CO2), the major product of metabolism, has a strong impact on cerebral blood vessels, a phenomenon known as cerebrovascular reactivity. Several vascular risk factors such as hypertension or diabetes dampen this response, making cerebrovascular reactivity a useful diagnostic marker for incipient vascular pathology, but its functional relevance, if any, is still unclear. Here, we found that GPR4, an endothelial H+ receptor, and endothelial Gαq/11 proteins mediate the CO2/H+ effect on cerebrovascular reactivity in mice. CO2/H+ leads to constriction of vessels in the brainstem area that controls respiration. The consequential washout of CO2, if cerebrovascular reactivity is impaired, reduces respiration. In contrast, CO2 dilates vessels in other brain areas such as the amygdala. Hence, an impaired cerebrovascular reactivity amplifies the CO2 effect on anxiety. Even at atmospheric CO2 concentrations, impaired cerebrovascular reactivity caused longer apneic episodes and more anxiety, indicating that cerebrovascular reactivity is essential for normal brain function. The site-specific reactivity of vessels to CO2 is reflected by regional differences in their gene expression and the release of vasoactive factors from endothelial cells. Our data suggest the central nervous system (CNS) endothelium as a target to treat respiratory and affective disorders associated with vascular diseases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety / Respiration Disorders / Cardiovascular System / Endothelium Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anxiety / Respiration Disorders / Cardiovascular System / Endothelium Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2020 Document type: Article